GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Emotra AB (XSAT:EMOT BTA) » Definitions » Net Cash per Share

Emotra AB (XSAT:EMOT BTA) Net Cash per Share : kr0.68 (As of Sep. 2021)


View and export this data going back to . Start your Free Trial

What is Emotra AB Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Emotra AB's Net Cash per Share for the quarter that ended in Sep. 2021 was kr0.68.

The historical rank and industry rank for Emotra AB's Net Cash per Share or its related term are showing as below:

XSAT:EMOT BTA' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.35   Med: 8.15   Max: 89.12
Current: 1.99

During the past 12 years, the highest Price-to-Net-Cash Ratio of Emotra AB was 89.12. The lowest was 1.35. And the median was 8.15.

XSAT:EMOT BTA's Price-to-Net-Cash is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 6.9 vs XSAT:EMOT BTA: 1.99

Emotra AB Net Cash per Share Historical Data

The historical data trend for Emotra AB's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emotra AB Net Cash per Share Chart

Emotra AB Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.95 -0.42 0.13 0.37

Emotra AB Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.37 0.14 -0.18 0.68

Competitive Comparison of Emotra AB's Net Cash per Share

For the Medical Devices subindustry, Emotra AB's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emotra AB's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Emotra AB's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Emotra AB's Price-to-Net-Cash falls into.



Emotra AB Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Emotra AB's Net Cash per Share for the fiscal year that ended in Dec. 2020 is calculated as

Net Cash per Share (A: Dec. 2020 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(4.302-2.007-0)/6.22987
=0.37

Emotra AB's Net Cash per Share for the quarter that ended in Sep. 2021 is calculated as

Net Cash per Share (Q: Sep. 2021 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(6.154-1.898-0)/6.2299
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Emotra AB  (XSAT:EMOT BTA) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Emotra AB Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Emotra AB's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Emotra AB (XSAT:EMOT BTA) Business Description

Traded in Other Exchanges
N/A
Address
Goteborgsvagen 74, Savedalen, SWE, 433 63
Emotra AB is engaged in developing medical devices for safe measurements of peripheral psychophysiological signals from the skin. The company provides information about psychological conditions and reaction.

Emotra AB (XSAT:EMOT BTA) Headlines

No Headlines